Deubiquitinating Enzymes as Promising Drug Targets for Infectious Diseases

  • Nanduri B
  • Suvarnapunya A
  • Venkatesan M
 et al. 
  • 22


    Mendeley users who have this article in their library.
  • 11


    Citations of this article.


Deubiquitinating enzymes (DUBs) remove ubiquitin and ubiquitin-like modifications from proteins and they have been known to contribute to processes relevant in microbial infection, such as immune responses pathways. Numerous viral and bacterial DUBs have been identified, and activities of several host DUBs are known to be modulated during the infection process, either by a pathogen or by a host. Recently there have been attempts to take advantage of this feature and design therapeutic inhibitors of DUBs that can be used to limit the spread of infection. This review is focused on exploring the potential of DUBs in the treatment of infectious diseases.

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document


  • Bindu Nanduri

  • Akamol E. Suvarnapunya

  • Malabi Venkatesan

  • Mariola J. Edelmann

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free